AMRN amarincorp.com Earnings per share growth this year

AMRN (Amarin Corporation plc) - company brandmark

Steady demand for cardiology treatments ensures the resilience of Amarin Corporation plc (AMRN) during any crisis. The year-over-year percentage growth rate of earnings per share confirms this foundation, where -1150.10 reflects the latest metric value. The uniqueness of the drug Vascepa integrates the company into global medical standards, although the product's maturity stage necessitates the search for new sales markets to combat generics.

AMRN (Amarin Corp) Earnings growth in current year history from 07/04/2022 to 11/17/2026

Analytical breakdowns and data insights for company Amarin (AMRN)

- current quotes and average value forecast:
Basic company analysis:Amarin Pharma AMRN
Signature product of amarincorp.com

This indicator measures the year-over-year growth rate of earnings per share, reflecting capital management efficiency and the business's ability to generate income. By analyzing the annual EPS growth rate, an investor assesses the impact of patent protection and the global expansion of Amarin Corporation plc (AMRN) on gross margins, which directly determines the sustainability of operating cash flow.